|
|
???tair.name??? >
???browser.page.title.author???
|
"po chin liang"???jsp.browse.items-by-author.description???
Showing items 76-100 of 175 (7 Page(s) Totally)
<< < 1 2 3 4 5 6 7 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2020-08-11T08:36:45Z |
Diffuse cirrhosis-like recurrence of hepatocellular carcinoma after curative resection
|
Ho C.-M.; PO-CHIN LIANG; Hu R.-H.; Lee P.-H. |
| 臺大學術典藏 |
2020-08-11T08:36:45Z |
Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy
|
PO-CHIN LIANG; Chen Y.-C.; Chiang C.-F.; Mo L.-R.; Wei S.-Y.; Hsieh W.-Y.; Lin W.-L. |
| 臺大學術典藏 |
2020-08-11T08:36:45Z |
Current role of selective internal radiation with yttrium-90 in liver tumors
|
Lau W.Y.; Teoh Y.L.; Win K.M.; Lee R.-C.; De Villa V.H.; Kim Y.H.J.; PO-CHIN LIANG; Santos-Ocampo R.S.; Lo R.H.G.; Lim K.B.L.; Tai D.W.M.; Ng D.C.E.; Irani F.G.; Gogna A.; Chow P.K.-H. |
| 臺大學術典藏 |
2020-08-11T08:36:45Z |
Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy
|
Chen B.-B.; Hsu C.-Y.; Yu C.-W.; PO-CHIN LIANG; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-08-11T08:36:44Z |
Combined Transarterial Embolization and Propranolol as Effective Treatment for Hepatic Hemangioma with Kasabach–Merritt Syndrome and Heart Failure in a Neonate
|
Shen W.-C.; PO-CHIN LIANG; Wu J.-F.; Hsu C.-T.; Chen H.-S.; Chen H.-L. |
| 臺大學術典藏 |
2020-08-11T08:36:44Z |
Pancreatic cancer screening in different risk individuals with family history of pancreatic cancer-a prospective cohort study in Taiwan
|
Chang M.-C.;Wu C.-H.;Yang S.-H.;Po-Chin Liang;Chen B.-B.;Jan I.-S.;Chang Y.-T.;Jeng Y.-M.; Chang M.-C.; Wu C.-H.; Yang S.-H.; PO-CHIN LIANG; Chen B.-B.; Jan I.-S.; Chang Y.-T.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-08-11T08:36:43Z |
A novel photodynamic therapy-based drug delivery system layered on a stent for treating cholangiocarcinoma
|
Chang Y.-T.; Wong J.-M.; Po-Chin Liang;Huang K.-W.;Tung C.-C.;Chang M.-C.;Chang F.-Y.;Wong J.-M.;Chang Y.-T.; PO-CHIN LIANG; Huang K.-W.; Tung C.-C.; Chang M.-C.; Chang F.-Y. |
| 臺大學術典藏 |
2020-08-11T08:36:43Z |
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
|
Kudo M.;Cheng A.-L.;Park J.-W.;Park J.H.;Po-Chin Liang;Hidaka H.;Izumi N.;Heo J.;Lee Y.J.;Sheen I.-S.;Chiu C.-F.;Arioka H.;Morita S.;Arai Y.; Kudo M.; Cheng A.-L.; Park J.-W.; Park J.H.; PO-CHIN LIANG; Hidaka H.; Izumi N.; Heo J.; Lee Y.J.; Sheen I.-S.; Chiu C.-F.; Arioka H.; Morita S.; Arai Y. |
| 臺大學術典藏 |
2020-08-11T08:36:42Z |
The efficacy of combination of induction chemotherapy and irreversible electroporation ablation for patients with locally advanced pancreatic adenocarcinoma
|
PO-CHIN LIANG; Song T.-Q.; Qiu Y.-D.; Li S.-P.; Huang K.-W.;Yang P.-C.;Pua U.;Kim M.-D.;Li S.-P.;Qiu Y.-D.;Song T.-Q.;Po-Chin Liang; Huang K.-W.; Yang P.-C.; Pua U.; Kim M.-D. |
| 臺大學術典藏 |
2020-08-11T08:36:42Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; PO-CHIN LIANG; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group; Wu C.-C.; Lee P.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Lu S.-N.;Wang J.-H.;Su C.-W.;Wang T.-E.;Dai C.-Y.;Chen C.-H.;Chen R.-C.;Yang S.-S.;Hung C.-F.;Huang S.-F.;Liao L.-Y.;Huo T.-I.;Wu C.-C.;Lee P.-H.;Ting C.-T.;Lee W.-C.;Chau G.-Y.;Wang C.-C.;Lee K.-T.;Huang Y.-H.;Ho M.-C.;Lin S.-M.;Huang G.-T.;Chen K.-Y.;Lin X.-Z.;Hwang J.-I.;Chiou Y.-Y.;Wang C.-K.;Hu J.-T.;Chen S.-C.;Po-Chin Liang;Lee R.-C.;Wu D.-K.;Lin C.-Y.;Lin C.-C.;Cheng A.-L.;Hsu C.;Chao Y.;Chen L.-T.;Wang P.-M.;Wang P.-M.;Hong J.-H.;Hsu H.-C.;Chen S.-W.;Leung S.W.;Cheng J.C.-H.;Wu J.-C.;Wu C.-Y.;Hsu Y.-C.;Hsu C.-W.;Ni Y.-H.;Lin C.-L.;Local Ablation Group, Surveillance Group, Diagnosis Group, Staging Group, Surgery Group, Tace/Tare/Hai Group, Target Therapy/Systemic Therapy Group, Radiotherapy Group, Prevention Group, Drafting Group; Huo T.-I.; Liao L.-Y.; Wang J.-H.; Su C.-W.; Wang T.-E.; Dai C.-Y.; Chen C.-H.; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Lu S.-N. |
| 臺大學術典藏 |
2020-08-11T08:36:41Z |
Comparing Western and Eastern criteria for sarcopenia and their association with survival in patients with pancreatic cancer
|
Wu C.-H.;Chang M.-C.;Lyadov V.K.;Po-Chin Liang;Chen C.-M.;Shih T.T.-F.;Chang Y.-T.; Chang Y.-T.; Wu C.-H.; Chang M.-C.; Lyadov V.K.; PO-CHIN LIANG; Chen C.-M.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-08-11T08:36:41Z |
Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma
|
Kao J.-H.; Liao S.-H.; Su T.-H.; Jeng Y.-M.; PO-CHIN LIANG; Chen D.-S.; Chen C.-H. |
| 臺大學術典藏 |
2020-08-11T08:36:41Z |
Multidisciplinary Taiwan consensus recommendations for the use of DEBDOX-TACE in hepatocellular carcinoma treatment
|
Wu R.-H.; Tsai W.-L.; Lin Y.-J.; Liu Y.-S.; Liang H.-L.; Lee R.-C.; Chen C.-H.; PO-CHIN LIANG; Hwang J.-I.; Wu D.-K.; Yu C.-Y.; Hung C.-H.; Huang C.-C.; Chang P.-Y.;Huang C.-C.;Hung C.-H.;Yu C.-Y.;Wu D.-K.;Hwang J.-I.;Po-Chin Liang;Wu R.-H.;Tsai W.-L.;Lin Y.-J.;Liu Y.-S.;Liang H.-L.;Lee R.-C.;Chen C.-H.; Chang P.-Y. |
| 臺大學術典藏 |
2020-08-11T08:36:40Z |
Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ? 2?cm with compensated liver cirrhosis
|
Wu C.-H.; PO-CHIN LIANG; Wu Y.-M.; Hu R.-H.; Lee P.-H.; Ho M.-C.; Ho C.-M.; Lin C.-H.; Lin C.-H.;Ho C.-M.;Wu C.-H.;Po-Chin Liang;Wu Y.-M.;Hu R.-H.;Lee P.-H.;Ho M.-C. |
| 臺大學術典藏 |
2020-08-11T08:36:40Z |
Pulsed-wave Ultrasound Hyperthermia Enhanced Nanodrug Delivery Combined with Chloroquine Exerts Effective Antitumor Response and Postpones Recurrence
|
Chiang C.-F.; Hsu Y.-H.; Liu C.-C.; PO-CHIN LIANG; Miaw S.-C.; Lin W.-L. |
| 臺大學術典藏 |
2020-08-11T08:36:40Z |
A case with small renal tumor complicated with pulmonary oil embolism after transcatheter arterial embolization
|
PO-CHIN LIANG; Chen Y.-A.; Chow P.-M.; Hsu J.-S.; Hsu J.-S.;Chow P.-M.;Po-Chin Liang;Chen Y.-A. |
| 臺大學術典藏 |
2020-08-11T08:36:38Z |
Prognostic factor analysis of irreversible electroporation for locally advanced pancreatic cancer – A multi-institutional clinical study in Asia
|
Yang P.-C.;Huang K.-W.;Pua U.;Kim M.-D.;Li S.-P.;Li X.-Y.;Po-Chin Liang; Yang P.-C.; Huang K.-W.; Pua U.; Kim M.-D.; Li S.-P.; Li X.-Y.; PO-CHIN LIANG |
| 臺大學術典藏 |
2019-10-14T06:01:36Z |
Comparison of Radiofrequency Ablation and Transarterial Chemoembolization for Hepatocellular Carcinoma in the Caudate Lobe
|
PO-CHIN LIANG;PO-HUANG LEE;YAO-MING WU;MING-CHIH HO;REY-HENG HU;CHENG-MAW HO;KAI-WEN HUANG;CHIH-HORNG WU;KAO-LANG LIU;Lee, Bo-Ching; Lee, Bo-Ching; KAO-LANG LIU; CHIH-HORNG WU; KAI-WEN HUANG; CHENG-MAW HO; REY-HENG HU; MING-CHIH HO; YAO-MING WU; PO-HUANG LEE; PO-CHIN LIANG |
| 臺大學術典藏 |
2018-09-10T18:07:31Z |
Comparing Western and Eastern criteria for sarcopenia and their association with survival in patients with pancreatic cancer
|
Wu, C.-H. and Chang, M.-C. and Lyadov, V.K. and Liang, P.-C. and Chen, C.-M. and Shih, T.T.-F. and Chang, Y.-T.; TIFFANY TING-FANG SHIH; PO-CHIN LIANG |
| 臺大學術典藏 |
2018-09-10T18:07:31Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Lu, S.-N. and Wang, J.-H. and Su, C.-W. and Wang, T.-E. and Dai, C.-Y. and Chen, C.-H. and Chen, R.-C. and Yang, S.-S. and Hung, C.-F. and Huang, S.-F. and Liao, L.-Y. and Huo, T.-I. and Wu, C.-C. and Lee, P.-H. and Ting, C.-T. and Lee, W.-C. and Chau, G.-Y. and Wang, C.-C. and Lee, K.-T. and Huang, Y.-H. and Ho, M.-C. and Lin, S.-M. and Huang, G.-T. and Chen, K.-Y. and Lin, X.-Z. and Hwang, J.-I. and Chiou, Y.-Y. and Wang, C.-K. and Hu, J.-T. and Chen, S.-C. and Liang, P.-C. and Lee, R.-C. and Wu, D.-K. and Lin, C.-Y. and Lin, C.-C. and Cheng, A.-L. and Hsu, C. and Chao, Y. and Chen, L.-T. and Wang, P.-M. and Wang, P.-M. and Hong, J.-H. and Hsu, H.-C. and Chen, S.-W. and Leung, S.W. and Cheng, J.C.-H. and Wu, J.-C. and Wu, C.-Y. and Hsu, Y.-C. and Hsu, C.-W. and Ni, Y.-H. and Lin, C.-L.; PO-CHIN LIANG |
| 臺大學術典藏 |
2018-09-10T18:07:31Z |
Multidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma Treatment
|
Chang, P.-Y. and Huang, C.-C. and Hung, C.-H. and Yu, C.-Y. and Wu, D.-K. and Hwang, J.-I. and Liang, P.-C. and Wu, R.-H. and Tsai, W.-L. and Lin, Y.-J. and Liu, Y.-S. and Liang, H.-L. and Lee, R.-C. and Chen, C.-H.; PO-CHIN LIANG |
| 臺大學術典藏 |
2018-09-10T18:07:31Z |
SIRveNIB: Selective internal radiation therapy versus sorafenib in Asia-Pacific patients with hepatocellular carcinoma
|
Chow, P.K.H. and Gandhi, M. and Tan, S.-B. and Khin, M.W. and Khasbazar, A. and Ong, J. and Choo, S.P. and Cheow, P.C. and Chotipanich, C. and Lim, K. and Lesmana, L.A. and Manuaba, T.W. and Yoong, B.K. and Raj, A. and Law, C.S. and Cua, I.H.Y. and Lobo, R.R. and Teh, C.S.C. and Kim, Y.H. and Jong, Y.W. and Han, H.-S. and Bae, S.-H. and Yoon, H.-K. and Lee, R.-C. and Hung, C.-F. and Peng, C.-Y. and Liang, P.-C. and Bartlett, A. and Kok, K.Y.Y. and Thng, C.-H. and Low, A.S.-C. and Goh, A.S.W. and Tay, K.H. and Lo, R.H.G. and Goh, B.K.P. and Ng, D.C.E. and Lekurwale, G. and Liew, W.M. and Gebski, V. and Mak, K.S.W. and Soo, K.C.; PO-CHIN LIANG |
| 臺大學術典藏 |
2018-09-10T18:07:27Z |
Comparison of Radiofrequency Ablation and Transarterial Chemoembolization for Hepatocellular Carcinoma in the Caudate Lobe
|
Lee, B.-C. and Liu, K.-L. and Wu, C.-H. and Huang, K.-W. and Ho, C.-M. and Hu, R.-H. and Ho, M.-C. and Wu, Y.-M. and Lee, P.-H. and Liang, P.-C.; PO-CHIN LIANG; KAO-LANG LIU; REY-HENG HU; CHENG-MAW HO |
| 臺大學術典藏 |
2018-09-10T18:04:58Z |
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
|
Kudo, M.;Cheng, A.-L.;Park, J.-W.;Park, J.H.;Liang, P.-C.;Hidaka, H.;Izumi, N.;Heo, J.;Lee, Y.J.;Sheen, I.-S.;Chiu, C.-F.;Arioka, H.;Morita, S.;Arai, Y.; PO-CHIN LIANG; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T18:04:57Z |
A novel photodynamic therapy-based drug delivery system layered on a stent for treating cholangiocarcinoma
|
Liang, P.-C. and Huang, K.-W. and Tung, C.-C. and Chang, M.-C. and Chang, F.-Y. and Wong, J.-M. and Chang, Y.-T.; PO-CHIN LIANG; KAI-WEN HUANG |
Showing items 76-100 of 175 (7 Page(s) Totally)
<< < 1 2 3 4 5 6 7 > >>
View [10|25|50] records per page
|
